[Federal Register Volume 61, Number 28 (Friday, February 9, 1996)]
[Notices]
[Pages 5002-5003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-2814]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


National Cancer Institute; Notice of Meetings of the National 
Cancer Advisory Board and its Subcommittees

    Pursuant to Pub. L. 92-463, notice is hereby given of the meetings 
of the National Cancer Advisory Board, National Cancer Institute, and 
its Subcommittees on February 26-28, 1996. Except as noted below, the 
meetings of the Board and its Subcommittees will be open to the public 
to discuss issues relating to committee business as indicated in the 
notice. Attendance by the public will be limited to space available.
    A portion of the Board meeting will be closed to the public in 
accordance with the provisions set forth in secs. 552b(c)(4) and 
552b(c)(6), Title 5, U.S.C. and sec. 10(d) of Pub. L. 92-463, for the 
review, discussion and evaluation of individual grant applications and 
for discussion of issues pertaining to programmatic areas and/or NCI 
personnel. These applications and discussions could reveal confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning the individuals associated with the 
applications or programs, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.
    The Committee Management Office, National Cancer Institute, 
National Institutes of Health, Executive Plaza North, Room 630E, 9000 
Rockville Pike, Bethesda, Maryland 20892 (301) 496-5708), will provide 
summaries of the meetings and rosters of the Board members upon 
request.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact Ms. Carole Frank, Committee Management Specialist, at (301) 
496-5708 in advance of the meeting.

    Name of Committee: Subcommittee on Basic and Environmental 
Sciences.
    Contact Person: Dr. Susan Sieber, Executive Secretary, National 
Cancer Institute, NIH, Building 31, Room 11A03, 9000 Rockville Pike, 
Bethesda, MD 20892; (301) 496-5946.
    Date of Meeting: February 26, 1996.
    Place of Meeting: Hyatt Regency Bethesda, One Bethesda Metro 
Center, Bethesda, MD 20814.
    Open: 5 pm to 7 pm.
    Agenda: To discuss basic and environmental sciences issues.

    Name of Committee: Subcommittee on Planning and Budget.
    Contact Person: Ms. Cherie Nichols, Executive Secretary, 
National Cancer Institute, NIH, Building 31, Room 11A19, 9000 
Rockville Pike, Bethesda, MD 20892; (301) 496-5515.
    Date of Meeting: February 26, 1996.
    Place of Meeting: Hyatt Regency Bethesda, One Bethesda Metro 
Center, Bethesda, MD 20814.
    Open: 7 pm to 9 pm.
    Agenda: To discuss the NIC budget and various planning issues.

    Name of Committee: National Cancer Advisory Board.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 600A, 
6130 Executive Boulevard, Bethesda, MD 20892-7405; (301) 496-5147.
    Date of Meeting: February 27-28, 1996.
    Place of Meeting: Conference Room 10, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: February 27--8 am to approximately 1 pm.
    Agenda: Report on activities of the President's Cancer Panel; 
the Director's Report on the National Cancer Institute; New 
Business; Scientific Presentations.
    Closed: February 27--3 to approximately 5 pm.
    Agenda: For review and discussion of individual grant 
applications and extramural/intramural programmatic and personnel 
policies.
    Open: February 28--8 am to adjournment.
    Agenda: Scientific Presentations; Subcommittee Reports; 
Continuing New Business; Board of Scientific Advisors Status Report; 
Innovative Funding Paradigms for Extramural Programs; Extramural 
Advisory Board.

    Name of Committee: Subcommittee on Cancer Centers.
    Contact Person: Dr. Brian Kimes, Executive Secretary, National 
Cancer Institute, NIH, Executive Plaza North, Room 300, 6130 
Executive Boulevard, Bethesda, MD 20892-7094; (301) 496-8537.
    Date of Meeting: February 27, 1996.
    Place of Meeting: Conference Room 8, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 1 pm to 3 pm.
    Agenda: To discuss the cancer centers.

    Name of Committee: Subcommittee on Information and Cancer 
Control.
    Contact Person: Mr. Paul Van Nevel, Executive Secretary, 
National Cancer Institute, NIH, Building 31, Room 10A31, 9000 
Rockville Pike, Bethesda, MD 20892; (301) 496-6631.
    Date of Meeting: February 27, 1996.
    Place of Meeting: Conference Room 9, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 1 pm to 3 pm.
    Agenda: To discuss information and cancer control issues.

    Name of Committee: Subcommittee on Clinical Investigations.
    Contact Person: Dr. Robert E. Wittes, Acting Executive 
Secretary, National Cancer Institute, NIH, Building 31, Room 3A52, 
9000 Rockville Pike, Bethesda, MD 20892; (301) 496-4291.
    Date of Meeting: February 27, 1996.
    
[[Page 5003]]

    Place of Meeting: Conference Room 9, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: Immediately following closed session of the full Board, 
approximately 5 pm, to adjournment.
    Agenda: To discuss the clinical investigation issues.

    Name of Committee: Subcommittee on Special Priorities.
    Contact Person: Ms. Iris Schneider, Executive Secretary, 
National Cancer Institute, NIH, Building 31, Room 11A48, 9000 
Rockville Pike, Bethesda, MD 20892; (301) 496-5534.
    Date of Meeting: February 27, 1996.
    Place of Meeting: Conference Room 8, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: Immediately following closed session of the full Board, 
approximately 5 pm, to adjournment.
    Agenda: To discuss issues related to special priorities.

    (CATALOG OF FEDERAL DOMESTIC ASSISTANCE PROGRAM NUMBERS: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control.)

    Dated: February 5, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-2814 Filed 2-8-96; 8:45 am]
BILLING CODE 4140-01-M